Clinical TrialsSearch results
Number of results: 832
Recruiting
- Treatment combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in patients with muscle invasive bladder cancer ineligible to cisplatin or Who Refuse Cisplatin
- Muscle Invasive Bladder Cancer
- Boulous Suliman
- 2022-03-14
Recruiting
- Trial of efficacy and safety of NS-229 versus placebo in patients with Eosinophilic Granulomatosis
- eosinophilic granulomatosis with polyangiitis(EGPA)
- Taira Masafumi
- 2023-12-21
Recruiting
- Uric acid Reduction Ameliorates Transition to End-stage renal disease Study (URATE Study)
- hyperuricemia chronic kidney disease (CKD)
- Society for Research on chronic kidney disease and hyperuricemia
- 2008-12-15
Recruiting
- VAS third-line eradication study
- Helicobacter pylori infection
- Soichiro Sue
- 2019-05-27
Recruiting
- VCM eradication therapy for penicillin allergy
- Helicobacter pylori infection
- Sue Soichiro
- 2020-10-26
Not yet recruiting
- A Long-term Extension Study of JNJ-77242113 in Participants with Moderate-to-Severe Plaque Psoriasis
- Plaque Psoriasis
- Nakano Masayoshi
- 2022-07-08
Not yet recruiting
- A Phase 3, Double-blind Maintenance Study Assessing Rocatinlimab in Moderate-to-severe AD (ROCKET-ASCEND)
- Atopic Dermatitis
- Jain Neal
- 2023-07-01
Not yet recruiting
- A Phase III, Two-Arm, Parallel, Randomized, Multi-Center, Open-Label, Global Study to Determine the Efficacy of Volrustomig (MEDI5752) Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy for First-Line Treatment of Patients With Metastatic Non-Small Cell Lung Cancer (mNSCLC).
- Non-small Cell Lung Cancer
- Hibi Kazushige
- 2024-03-06
Not yet recruiting
- A randomized competitive trial of BCG instillation therapy with UFT for prevention of superficial bladder cancer recurrence.
- Bladder cancer
- Study Group of Urothelial Cancer Kitasato institute hospital Kitasato University Kyorin University Keio University Showa University Teikyo University Tokyo Medical University Jikei University Toho University
- 2009-05-01
Not yet recruiting
- A Study of Guselkumab in Pediatric Participants with Moderately to Severely Active Crohn's Disease
- Crohn's Disease
- Nakama Takahiro
- 2023-09-21